Effect of an aldose reductase inhibiting agent on limited joint mobility in IDDM.
Rosenbloom
A L
AL
Buithieu
M
M
Jelliffe
K A
KA
Aitchison
R D
RD
Truglia
J A
JA
D000328:Adult; D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D001794:Blood Pressure; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000503:physiopathology; D004311:Double-Blind Method; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006339:Heart Rate; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D008297:Male; D009068:Movement; D009460:Neurologic Examination; D010793:Phthalazines / Q000627:therapeutic use*
D000449:Aldehyde Reductase; D006442:Glycated Hemoglobin; D010793:Phthalazines; C042829:ponalrestat